Phoenix Biotech Acquisition Corp. (PBAX)
Stock analysis · NASDAQ · Financial Services · Shell Companies
Phoenix Biotech Acquisition Corp. (PBAX) is a publicly traded company in the Financial Services sector. Latest price: $5.85. Market cap $36.47M. Trailing PE -0.27. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.
Get full analysis → Short-Term Analysis →Proprietary Signals
About Phoenix Biotech Acquisition Corp.
Phoenix Biotech Acquisition Corp. currently lacks substantial business operations. The company's primary objective is to complete a strategic business combination, such as a merger, asset acquisition, share exchange, or other form of reorganization, with one or more suitable enterprises. Its focus is on identifying and integrating with a firm engaged in the healthcare or healthcare-related industries within the United States or Europe. This entity was established in 2021 and maintains its headquarters in Oakland, California.
Valuation
| P/E (TTM) | -0.27× |
|---|---|
| P/S (TTM) | 0.00× |
| P/B | -8.09× |
| P/FCF (TTM) | -3.01× |
| EV / EBITDA | -14.62× |
| EV / Sales | 0.00× |
| Earnings Yield | -38.62% |
| Free Cash Flow Yield | -33.18% |
Fundamentals
| Enterprise Value | $44.16M |
|---|---|
| Net Income (TTM) | -$14.09M |
| Free Cash Flow (TTM) | -$12.96M |
| Net Debt | $7.69M |
| Working Capital | -$30.86M |
| Gross Margin | 0.00% |
| Operating Margin | 0.00% |
| Net Margin | 0.00% |
| Return on Equity | 766.14% |
| Return on Invested Capital | 79.91% |
Peers
Recent News
- No recent news available.
Related
Browse more tickers: sitemap